Gesine Meyer-Rath, MD, PhDResearch Assistant Professor, Global Health
BiographyGesine Meyer-Rath is a Research Assistant Professor at the Center for Global Health and Development of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV and antiretroviral treatment in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining CGHD she has worked in the Pediatrics Department of Charité University Hospital Berlin and with the World Health Organization on the ChoICE team’s generalized cost-effectiveness analysis and the calculation of the cost of WHO’s ’3 by 5′ programme. Since 2006, she has been mainly based in Johannesburg, collecting data for her PhD in health economics at the London School of Hygiene and Tropical Medicine. She holds a MD/PhD in physiology from Free University Berlin.
- Free University of Berlin , PhD
- Free University of Berlin , MD
- Published on 3/10/2014
Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Res Treat. 2014; 2014:235483.
- Published on 1/9/2014
Terris-Prestholt F, Foss AM, Cox AP, Heise L, Meyer-Rath G, Delany-Moretlwe S, Mertenskoetter T, Rees H, Vickerman P, Watts CH. Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis. 2014; 14(1):14.
- Published on 12/10/2013
Jeffrey W. Eaton, Nicolas A. Menzies, John Stover, Valentina Cambiano, Leonid Chindelevitch, Gesine Meyer-Rath et al:. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health. 2013; 1(2):23-34.
- Published on 7/1/2013
Schnippel K, Long L, Meyer-Rath G, Sanne I, Rosen S, Stevens W. Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. S Afr Med J. 2013 Jul; 103(7):436.
- Published on 6/28/2013
Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013; 8(6):e67910.
- Published on 3/1/2013
Meyer-Rath G, Brennan AT, Fox MP, Modisenyane T, Tshabangu N, Mohapi L, Rosen S, Martinson N. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2013 Mar 1; 62(3):322-328.
- Published on 1/14/2013
Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, Moultrie H, Fairlie L, Coovadia A, Rosen S. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50.
- Published on 1/14/2013
Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013 Feb; 103(2):101-6.
- Published on 11/1/2012
Meyer-Rath G, Miners A, Santos AC, Variava E, Venter WD. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa. J Acquir Immune Defic Syndr. 2012 Nov 1; 61(3):e25-32.
- Published on 8/7/2012
Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, Govindasamy D, van Schaik N, Wood R, Bekker LG. Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study. PLoS Med. 2012; 9(8):e1001281.
View 7 more publications:View full profile at BUMC